Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other Accumulated Expenses (2020 - 2026)

Journey Medical filings provide 6 years of Other Accumulated Expenses readings, the most recent being $455000.0 for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 13.83% to $455000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $455000.0, a 13.83% decrease, with the full-year FY2025 number at $455000.0, down 13.83% from a year prior.
  • Other Accumulated Expenses hit $455000.0 in Q4 2025 for Journey Medical, up from $359000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.7 million in Q1 2022 to a low of $195000.0 in Q4 2023.
  • Median Other Accumulated Expenses over the past 5 years was $559500.0 (2022), compared with a mean of $732166.7.
  • Biggest five-year swings in Other Accumulated Expenses: tumbled 75.32% in 2023 and later surged 263.64% in 2025.
  • Journey Medical's Other Accumulated Expenses stood at $450000.0 in 2021, then decreased by 8.22% to $413000.0 in 2022, then crashed by 52.78% to $195000.0 in 2023, then surged by 170.77% to $528000.0 in 2024, then dropped by 13.83% to $455000.0 in 2025.
  • The last three reported values for Other Accumulated Expenses were $455000.0 (Q4 2025), $359000.0 (Q3 2025), and $561000.0 (Q2 2025) per Business Quant data.